BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids, derived from a protective protein found in human gastric juice. It has been extensively studied in preclinical (animal) models for its potential roles in accelerating healing of tendons, ligaments, muscle, and gastrointestinal tissue.
Mechanism of Action
BPC-157 is believed to act through multiple mechanisms, including modulation of growth factor signaling and promotion of angiogenesis (new blood vessel formation). It has been shown to upregulate VEGF expression and activate the nitric oxide (NO) system, which plays a critical role in vascular repair.
Tendon and Ligament Research
Some of the most compelling preclinical evidence for BPC-157 involves tendon and ligament healing. Multiple rodent studies have demonstrated accelerated tendon-to-bone healing and improved biomechanical properties of repaired tendons following BPC-157 administration. These effects appear to involve modulation of tendon fibroblast activity and promotion of organized collagen deposition.
Gastrointestinal Research
Given its gastric origin, BPC-157 has been studied extensively in models of gastrointestinal injury. Research in rodent models has demonstrated protective effects against gastric ulcers, inflammatory bowel conditions, and gut-brain axis disruption following systemic toxin exposure.
Current Research Status
While the preclinical evidence base for BPC-157 is substantial, large-scale human clinical trials remain limited. The compound has not received regulatory approval from major agencies for any therapeutic indication. Current research interest remains high, particularly for potential applications in musculoskeletal medicine.
Research Disclaimer: This article is for educational purposes only and does not constitute medical advice.